Conglomerates seeking their futures from pharmaceutical industry?

Published: 2007-05-11 06:59:00

Updated: 2007-05-11 06:59:00

While a floating rumor attracted keen interests to the public that Samsung, the top conglomerate group in Korea, may step into the pharmaceutical industry soon, some observers said that local conglomerates could stage a role of pinchhitter at the pharmaceutical industry in an attempt to explore t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK